Simmons & Simmons has advised Gimv on the deal.
Gimv invested in Apraxon Group, a leading homecare provider group in Germany. Gimv is a European investment company with approximately EUR 2 billion of assets under management.
This is the latest deal where Simmons’ Munich team has advised Gimv on a private equity transaction. Other recent matters include advising Köberl Group, a Gimv portfolio company, on the acquisition of 089 Immobilienmanagement in late 2020.
Apraxon offers high-quality wound care for people with chronic wounds. The company connects patients, medical doctors, nursing services providers/homes and health insurance companies. This investment marks Gimv’s 23rd interest in companies in the healthcare and life sciences sector.
On its investment in Apraxon, Gimv was advised by a team led by Munich private equity partner Dr Fabian von Samson-Himmelstjerna (Picture).
Involved fees earner: Fabian von Samson-Himmelstjerna – Simmons & Simmons;
Law Firms: Simmons & Simmons;
Clients: Gimv NV;